Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -3.179% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Cc1ccc(S(=O)(=O)NC2CC2)cc1
b.) Cc1ccnc(N2CCCC(C(=O)NCc3cccs3)C2)n1
c.) CC1CCc2sc3ncn4nc(C(=O)NCc5ccco5)nc4c3c2C1
Answer: b. Cc1ccnc(N2CCCC(C(=O)NCc3cccs3)C2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccnc(N2CCCC(C(=O)NCc3cccs3)C2)n1
Cc1ccnc(N2CCCC(C(=O)NCc3cccs3)C2)n1
1-(4-methylpyrimidin-2-yl)-N-(thiophen-2-ylmethyl)piperidine-3-carboxamide